Haemonetics HAE
NYSE HAE
$108.58 +0.17 (+0.16%)
At close: Aug 20, 2026 · 10:17 AM UTC

Haemonetics (HAE) Gross Profit Growth (1y) (2010 - 2026)

Haemonetics (HAE) Gross Profit Growth (1y) (2010 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Gross Profit Growth (1y) (Qtr)
1 Abbott Laboratories 199.70 Bn 194.09 Bn 7.27 Bn 15.59%
2 Stryker 129.93 Bn 126.46 Bn 4.50 Bn 17.10%
3 Medtronic 120.49 Bn 111.27 Bn 6.41 Bn 10.88%
4 Boston Scientific 74.60 Bn 74.06 Bn 3.85 Bn 12.38%
5 Edwards Lifesciences 52.68 Bn 48.42 Bn 1.35 Bn 13.54%
6 Dexcom 34.78 Bn 32.84 Bn 830.00 Mn 20.50%
7 GE HealthCare Technologies 33.83 Bn 31.72 Bn 2.18 Bn 9.82%
8 Koninklijke Philips 26.44 Bn 23.12 Bn 4.55 Bn 4.20%
9 Steris 23.18 Bn 22.69 Bn 684.20 Mn 8.95%
10 Haemonetics 4.93 Bn 4.70 Bn 202.80 Mn 5.49%

Historic Data

Download Data
DateValue
Jun 27, 2026 5.49%
Mar 28, 2026 2.67%
Dec 27, 2025 4.57%
Sep 27, 2025 3.90%
Jun 28, 2025 9.90%
Mar 29, 2025 9.75%
Dec 28, 2024 8.82%
Sep 28, 2024 9.93%
Jun 29, 2024 4.58%
Mar 30, 2024 12.58%
Dec 30, 2023 12.07%
Sep 30, 2023 8.00%
Jul 1, 2023 17.57%
Apr 1, 2023 14.63%
Dec 31, 2022 14.54%
Oct 1, 2022 28.84%
Jul 2, 2022 31.62%
Apr 2, 2022 66.63%
Jan 1, 2022 15.22%
Oct 2, 2021 15.88%